RN Mobile Menu

Search form


Sjögren's Syndrome

Cold fingers? Is it primary or secondary Raynaud’s?

Raynaud’s phenomenon affects up to 5% of the general population, but for 37% of patients, it leads to connective tissue disease. In this slideshow, we compare primary and secondary Raynaud’s.  (Raynaud’s phenomenon, ©Twinschoice/Shutterstock.com)

Sjögren's Syndrome


The American College of Rheumatology and the European League Against Rheumatism have published an international set of classification criteria for primary Sjögren's syndrome.


The Rheumatology Journal Club resumes its Twitter chat series this week with a focus on rheumatological immune-related adverse events in immunotherapy.


Clinicians should pay more attention to neurological signs in patients with high-activity primary Sjogren’s Syndrome or those with prior neurological involvements.


Autoantibodies against carbamylated proteins in Sjögren’s syndrome could be used as a new biomarker.

B-cells that are active in lupus may also play a role in Sjögren’s syndrome. A new study finds that the same B-cell depleter drug, belimumab (Benlysta) approved for lupus, may also benefit Sjögren’s patients.

The increased risk for venous thromoboembolism after surgery among patients with rheumatic disease appears to trace to those conditions with a clotting component. However, joint surgery in general has a high risk of this complication.


Subscribe to Sjögren's Syndrome on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.